The Transition From First-Line to Second-Line Therapy in Multiple Sclerosis
Crossref DOI link: https://doi.org/10.1007/s11940-015-0354-5
Published Online: 2015-04-26
Published Print: 2015-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dörr, Jan
Paul, Friedemann
Text and Data Mining valid from 2015-04-26
Version of Record valid from 2015-04-26
Article History
First Online: 26 April 2015
Free to read: This content has been made available to all.